Zobrazeno 1 - 10
of 30 884
pro vyhledávání: '"diffuse large-B cell lymphoma"'
Autor:
Priya Das, MBBS, Kaustubh Gupta, MBBS, MD, Gaurav Raj, MBBS, MD, Vini Tandon, MBBS, MD, Namrata Punit Awasthi, MBBS, MD, Yatendra Parashar, MBBS, MD
Publikováno v:
Radiology Case Reports, Vol 19, Iss 10, Pp 4440-4444 (2024)
Non-Hodgkin's lymphoma are neoplasms derived from T cells and B cells and their precursors in the lymphoid system with higher susceptibility in involvement of extra-nodal sites. Predominant ureteric involvement is an unusual presentation. We present
Externí odkaz:
https://doaj.org/article/ea090ad211c2476ab03d3239424fa979
Autor:
WANG Boen, CHEN Siyuan, SHI Qing, ZHANG Muchen, YI Hongmei, DONG Lei, WANG Li, CHENG Shu, XU Pengpeng, ZHAO Weili
Publikováno v:
Shanghai Jiaotong Daxue xuebao. Yixue ban, Vol 44, Iss 9, Pp 1162-1168 (2024)
Objective·To analyze the clinicopathologic characteristics of patients with kidney-involved diffuse large B-cell lymphoma (DLBCL), including clinical characteristics, pathological characteristics, gene mutation profiles, and prognostic factors.Metho
Externí odkaz:
https://doaj.org/article/ff1996797fef49e89966ce3ece7213f2
Publikováno v:
Health and Quality of Life Outcomes, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Background This study evaluates the health-related quality of life (HRQoL) of persons with diffuse large B-cell lymphoma (DLBCL) by using EQ-5D-5L and SF-6Dv2 and compares the measurement properties of the two instruments. Method DLBCL patie
Externí odkaz:
https://doaj.org/article/e4ac6f79db8d44baa6456db1c702e899
Autor:
Hatice Şanlı, Handan Merve Erol Mart, Devrim Deniz Kuşçu, Işınsu Kuzu, Aylin Okçu Heper, Ayça Kırmızı, Bengü Nisa Akay
Publikováno v:
Turkderm Turkish Archives of Dermatology and Venereology, Vol 58, Iss 3, Pp 66-74 (2024)
Background and Design: Primary cutaneous B-cell lymphomas (PCBCLs) have not been well characterized due to their relatively low incidence and heterogeneous clinical features. Materials and Methods: Data of 29 patients with primary cutaneous marginal
Externí odkaz:
https://doaj.org/article/0529128a64c94baeaa9ca143d1334461
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1094-1102 (2024)
Introduction: Erythema nodosum (EN) is the most common form of panniculitis. EN can be idiopathic or secondary to an underlying systemic disease, infection, drug use, or tumor. CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL) is a relapsed and
Externí odkaz:
https://doaj.org/article/fd16a062dd5c47079c89fee139edfe97
Autor:
Sylvia Zöphel, Nadja Küchler, Johanna Jansky, Cora Hoxha, Gertrud Schäfer, Julius J. Weise, Joanne Vialle, Lea Kaschek, Gebhard Stopper, Hermann Eichler, Daniela Yildiz, Alina Moter, Philipp Wendel, Evelyn Ullrich, Claudia Schormann, Torben Rixecker, Onur Cetin, Frank Neumann, Patrick Orth, Moritz Bewarder, Markus Hoth, Lorenz Thurner, Eva C. Schwarz
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-9 (2024)
Abstract Assessing the prognosis of patients with aggressive non-Hodgkin B cell lymphoma mainly relies on a clinical risk score (IPI). Standard first-line therapies are based on a chemo-immunotherapy with rituximab, which mediates CD16-dependent anti
Externí odkaz:
https://doaj.org/article/c26da19e6df140a2bd9fa86950fc9b73
Autor:
Ashwini K. Yenamandra, Rebecca B. Smith, Adam C. Seegmiller, Brianna N. Smith, Debra L. Friedman, Christine M. Smith
Publikováno v:
DNA, Vol 4, Iss 3, Pp 318-327 (2024)
Diffuse large B cell lymphoma, not otherwise specified (DLBCL, NOS) is the most common type of non-Hodgkin lymphoma (NHL). Significant efforts have been focused on utilizing advanced genomic technologies to further subclassify DLBCL, NOS into clinica
Externí odkaz:
https://doaj.org/article/d063c8b14ae9467abb03607aa4115a26
Publikováno v:
Journal of Blood Medicine, Vol Volume 15, Pp 407-419 (2024)
Jing Wang,1,* Lei Tian,2,* Weilong Zhang,1,* Shuhan Tang,1 Wei Zhao,1 Yu Guo,1 Chaoling Wu,1 Yuansheng Lin,1 Xiaoyan Ke,1 Hongmei Jing1 1Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, 100191
Externí odkaz:
https://doaj.org/article/0c857ff6997545e5a7c314970eb40843
Autor:
Jingnan Wang, Xin Liu, Yunpeng Wu, Qiuzi Zhong, Tao Wu, Yong Yang, Bo Chen, Hao Jing, Yuan Tang, Jing Jin, Yueping Liu, Yongwen Song, Hui Fang, Ningning Lu, Ning Li, Yirui Zhai, Wenwen Zhang, Min Deng, Shulian Wang, Fan Chen, Lin Yin, Chen Hu, Shunan Qi, Yexiong Li
Publikováno v:
Journal of the National Cancer Center, Vol 4, Iss 3, Pp 249-259 (2024)
Objective: To evaluate whether improved progression-free survival (PFS) from radiotherapy (RT) translates into an overall survival (OS) benefit for diffuse large B-cell lymphoma (DLBCL). Methods: A systematic literature search identified randomized c
Externí odkaz:
https://doaj.org/article/c38fbd04b6d14543bb49387430da6169
Publikováno v:
Medical Journal of Dr. D.Y. Patil Vidyapeeth, Vol 17, Iss 4, Pp 707-712 (2024)
Background: Diffuse large B cell lymphoma (DLBCL) within non-Hodgkin lymphoma has several morphologic and clinicopathologic variants. DLBCL has two prognostically important subtypes, germinal center B cell (GCB) and nongerminal center (Non-GCB) with
Externí odkaz:
https://doaj.org/article/0cda9f8f6da84db7a38f2098fcbc39d4